Development and Validation of a Bioanalytical LC-MS/MS Method for Simultaneous Determination of Sirolimus in Porcine Whole Blood and Lung Tissue and Pharmacokinetic Application with Coronary Stents

Sirolimus is a hydrophobic macrolide compound that has been used for long-term immunosuppressive therapy, prevention of restenosis, and treatment of lymphangioleiomyomatosis. In this study, a simple and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) was developed and validated for the simultaneous determination of sirolimus in both porcine whole blood and lung tissue. Blood and lung tissue homogenates were deproteinized with acetonitrile and injected into the LC-MS/MS system for analysis using the positive electrospray ionization mode. The drug was separated on a C18 reversed phase column with a gradient mobile phase (ammonium formate buffer (5 mM) with 0.1% formic acid and acetonitrile) at 0.2 mL/min. The selected reaction monitoring transitions of m/z 931.5 → 864.4 and m/z 809.5 → 756.5 were applied for sirolimus and ascomycin (the internal standard, IS), respectively. The method was selective and linear over a concentration range of 0.5–50 ng/mL. The method was validated for sensitivity, accuracy, precision, extraction recovery, matrix effect, and stability in porcine whole blood and lung tissue homogenates, and all values were within acceptable ranges. The method was applied to a pharmacokinetic study to quantitate sirolimus levels in porcine blood and its distribution in lung tissue following the application of stents in the porcine coronary arteries. It enabled the quantification of sirolimus concentration until 2 and 14 days in blood and in lung tissue, respectively. This method would be appropriate for both routine porcine pharmacokinetic and bio-distribution studies of sirolimus formulations.     

Development of an LC-MS/MS Method for ARV-110, a PROTAC Molecule,and Applications to Pharmacokinetic Studies

ARV-110, a novel proteolysis-targeting chimera (PROTAC), has been reported to show satisfactory safety and tolerability for prostate cancer therapy in phase I clinical trials. However, there is a lack of bioanalytical assays for ARV-110 determination in biological samples. In this study, we developed and validated an LC-MS/MS method for the quantitation of ARV-110 in rat and mouse plasma and applied it to pharmacokinetic studies. ARV-110 and pomalidomide (internal standard) were extracted from the plasma samples using the protein precipitation method. Sample separation was performed using a C18 column and a mobile phase of 0.1% formic acid in distilled water–0.1% formic acid in acetonitrile (30:70, v/v). Multiple reaction monitoring was used to quantify ARV-110 and pomalidomide with ion transitions at m/z 813.4 → 452.2 and 273.8 → 201.0, respectively. The developed method showed good linearity in the concentration range of 2–3000 ng/mL with acceptable accuracy, precision, matrix effect, process efficiency, and recovery. ARV-110 was stable in rat and mouse plasma under long-term storage, three freeze-thaw cycles, and in an autosampler, but unstable at room temperature and 37 °C. Furthermore, the elimination of ARV-110 via phase 1 metabolism in rat, mouse, and human hepatic microsomes was shown to be unlikely. Application of the developed method to pharmacokinetic studies revealed that the oral bioavailability of ARV-110 in rats and mice was moderate (23.83% and 37.89%, respectively). These pharmacokinetic findings are beneficial for future preclinical and clinical studies of ARV-110 and/or other PROTACs.     

Development and Verification of a Precolumn Derivatization LC-MS/MS Method for the Pharmacokinetic Study of Houttuynine of Houttuynia Essential Oil

Houttuynia essential oil (HEO) has excellent antiviral, anti-inflammatory, and other pharmacological effects, but the lack of effective analytical methods to quantify HEO in plasma has hindered its better clinical monitoring. Houttuynine (Hou) is one of the main active ingredients and quality control substances of HEO, so the pharmacokinetic study of HEO could be conducted by determining Hou blood concentration. Hou is active and not stable in plasma, which makes its blood concentration difficult to measure. In this work, a novel liquid chromatography tandem mass spectrometry (LC-MS/MS) method for Hou determination in rat blood was established that involves Hou being derivatized with 2, 4-dinitrophenylhydrazine to form a stable compound to prevent degradation. Herein, p-Tolualdehyde-2,4-dinitrophenylphenylhydrazone was selected as an internal standard substance and the LC-MS/MS method was evaluated for selectivity, precision, accuracy, calibration limit, matrix effect, recovery, and stability. Good linearity (r² = 0.998) was reached in the range of 2–2000 ng/mL, and the lower limit of quantification of Hou was determined to be 2 ng/mL. The mean intra-assay accuracy ranged from 77.7% to 115.6%, whereas the intra-assay precision (relative standard deviation, RSD) was below 11.42%. The matrix effect value for Hou in rat plasma was greater than 75%, and for the internal standard (IS) it was 104.56% ± 3.62%. The extraction recovery of Hou were no less than 90%, and for the IS it was 96.50% ± 4.68%. Our method is sensitive and reliable and has been successfully applied to the pharmacokinetic analysis of Hou in rats given HEO via gavage and injection.     

LC-MS/MS法快速高效检测尿液中尼古丁及其9种代谢物

以氘代尼古丁、氘代可的宁、3-OH-氘代可的宁、氘代尼古丁葡萄糖醛酸复合物、氘代可的宁葡萄糖醛酸复合物、3-OH-氘代可的宁葡萄糖醛酸复合物作内标, 在LC-MS/MS的大气压化学电离(APCI)离子化模式下, 建立了快速检测吸烟者尿液中尼古丁及其9种代谢物的方法, 并对19个实际样品进行了测试和判别分析(DA). 实验前处理简单, 色谱运行时间仅为3.8 min. 结果表明, 尼古丁及其代谢物的精密度在0.5%～5.5%之间, 回收率在94%～109%之间, 线性相关系数均大于0.995. DA分析充分区别开了不同量的吸烟者, 进一步的相关性分析表明吸烟者24 h尿液中的尼古丁及其9种代谢物含量与卷烟抽吸量的分析因子之间均有较强正相关性.     

LC-MS/MS方法快速检测血浆中小檗碱的浓度

小檗碱在生物体内以极低的浓度发挥着良好的疗效,准确测定其血药浓度对其药理学性质的研究具有重要意义。本文建立了高效液相色谱-质谱联用快速测定血浆中小檗碱浓度的方法,采用Waters XTerraTM MSC18色谱柱(2.1×50mm,3.5μm),柱温25℃,以0.2%醋酸水溶液-乙腈为流动相梯度洗脱,流速为0.2mL/min,以苯妥英为内标。质谱采用电喷雾电离源,以选择反应监测模式进行定量分析,血浆样品用乙腈直接沉淀处理。结果表明,小檗碱在0.01～0.5μg/mL浓度范围线性关系良好,最低检测浓度为5ng/mL(S/N=3)。日内、日间RSD均小于15%(n=5)。本文建立的方法操作简单、灵敏度高、分析时间短,适用于小檗碱血药浓度监测及药代动力学研究。     

液相色谱-串联质谱法测定中成药中马兜铃酸A含量

中成药样品用丙酮作为溶剂进行超声波萃取,所得提取液在不超过50℃的水浴中加热减压蒸发至干。加入水-乙酸-乙腈(49+1+50)混合溶液2.0 mL溶解残渣,所得溶液供液相色谱-串联质谱(LC-MS/MS)分析用,上述混合溶液在以后分析中用作流动相。Kromasil C_(18)柱用作色谱柱固定相,在MS/MS分析中,选择大气压化学电离为离子源,以正离子扫描,选择离子检测模式和二级选择反应检测模式对马兜铃酸A进行定量和定性检测。以[M+NH_4]+(m/z 359)为母离子,选择其二级离子中信号较强的碎片离子[M—NO_2+H]+(m/z 298)作为定量及定性离子,并以碎片离子[M—CO_2+H]+(m/z 296)为辅助定性离子。测定马兜铃酸A的线性范围在0.2～10.5 mg·L~(-1)之间,方法的测定下限(10S/N)为0.07 mg·L~(-1)。在3种不同浓度水平的标准加入量的条件下进行回收试验,测得回收率在89%～95%之间,测定值的相对标准偏差(n=6)均小于5.5%。     

LC-MS/MS Method for the Quantitation of Cefotetan in Human Plasma and Its Application to Pharmacokinetic Study

A rapid and sensitive liquid chromatography-tandem mass spectrometry（LC-MS/MS） method for the de- termination of cefotetan in human plasma was developed and validated. After the protein precipitation of sample with acetonitrile, the analyte and internal standard（IS）, tramadol, were separated on a Zorbax XDB C8 column using ace- tonitrile/1%（volume fraction） formic acid（volume ratio 35：65, pH=2.5） as mobile phase at a flow rate of 1.0 mL/min with a 1 ： 1 split. The detection was performed by electrospray ionization with positive ion mode, followed by multiple reaction monitoring of the transitions for cefotetan at m/z 576.3→460.2（quantifier） and m/z 576.3→432.2（qualifier） and for IS at m/z 264.1→58.1. Cefotetan and IS were eluted at 1.86 and 1.87 rain, respectively. The assay was linear over the concentration range of 0.1-100 gg/mL for 20 μL of human plasma only with intra- and inter-day preci- sions（expressed as the relative standard deviation） of less than 6.62% and accuracies（as relative error） of ＋1.31%. The method was applied to the pharmacokinetic study of a l-h intravenous infusion of 1.0 g of cefotetan disodium for human volunteers（n=6）.     

粮谷中双苯唑菌醇残留量的液相色谱-质谱/质谱检测

建立了糙米、玉米、大麦、小麦、荞麦、大米、高粱、燕麦中双苯唑菌醇残留量的液相色谱-质谱/质谱测定方法.样品经乙腈提取,氨基(NH2)固相萃取柱净化,液相色谱-质谱/质谱仪测定,外标法定量.方法的定量下限为0.025 mg/kg,粮谷样品在0.025、0.050、0.500 mg/kg添加水平的平均回收率为 79% ～92%,相对标准偏差为4.8% ～10.8%,可以满足进出口谷物中双苯唑菌醇残留量的检测需要.     

液相色谱-串联质谱法测定食品中合成色素

提出了液相色谱-串联质谱法测定食品中8种合成色素柠檬黄、苋菜红、胭脂红、日落黄、诱惑红、亮蓝、赤藓红和偶氮玉红的含量。固体(半固体)样品经乙醇-氨水-水(70+1+29)溶液溶解,所得滤液烘干后用水溶解,经Waters Atlantis dC18色谱柱(2.1 mm×150 mm,5μm)分离,用甲醇和10 mmol.L-1乙酸铵溶液以不同体积比混合进行梯度洗脱,采用电喷雾正离子模式串联质谱检测。8种合成色素的质量浓度均在50μg.L-1以内与其峰面积呈线性关系,检出限(3S/N)在0.003～0.020 mg.kg-1之间。方法应用于食品样品中8种合成色素的测定,回收率在83.0%～112.0%之间,测定值的相对标准偏差(n=6)均小于5%。     

液相色谱-串联质谱法测定食品中甲基磺草酮

食品用乙腈-水(3+1)溶液进行提取,经凝胶色谱、固相萃取柱净化后,用液相色谱-串联质谱法进行测定和确证,外标法定量。色谱分离用甲醇和甲酸-水(0.1+99.9)溶液以不同体积比混合为流动相梯度洗脱,采用负离子模式电喷雾离子源在多反应监测模式下进行检测。甲基磺草酮的质量浓度在0.01~0.2 mg·L-1范围内与其峰面积呈线性关系。以4种食品样品为基体,加入3种浓度水平的甲基磺草酮标准做回收试验,测得回收率在73.2%~100.6%之间;测定值的相对标准偏差(n=10)在4.1%~11%之间。     

液相色谱-串联质谱法测定鸡饲料中硝基咪唑类药物

提出了鸡饲料中5种硝基咪唑类药物(甲硝唑、洛硝哒唑、二甲硝唑、替硝唑和奥硝唑)的液相色谱-串联质谱分析方法。鸡饲料样品经乙酸乙酯-5g.L-1碳酸钠混合溶液提取后,取有机相蒸发至干。用0.1mol·L-1磷酸溶液溶解残余物,HLB柱固相萃取净化,所得的乙腈洗脱液经C8色谱柱为分离柱,甲醇和水混合溶液为流动相作梯度淋洗,采用正离子模式多反应监测。5种硝基咪唑类药物的线性范围均为10～500μg.L-1,检出限(3S/N)均为10μg.kg-1。加标回收率为79.4%～91.3%,批内相对标准偏差(n=6)为5.5%～13.9%,批间相对标准偏差(n=6)为6.7%～18.2%。     

非衍生化/液相色谱-串联质谱法测定食品中的二硫代氨基甲酸酯类农药残留

通过优化质谱、液相色谱和萃取缓冲液等条件,建立了一种简单、快速、灵敏测定食品中二硫代氨基甲酸酯的方法。在优化条件下,代森锌(EBDC)、丙森锌(PBDC)的线性范围为2～100μg/L,相关系数均不小于0.997。在花椰菜、萝卜和豌豆中EBDC和PBDC的检出限(S/N>3)为2μg/kg;萝卜和豌豆中EB-DC和PBDC的定量下限(S/N>10)为10μg/kg,而花椰菜中EBDC和PBDC的定量下限(S/N>10)为15μg/kg。在花椰菜、萝卜和豌豆基质中加标5～100μg/kg的EBDC和PBDC时,测定加标回收率为83%～96%,相对标准偏差为4.4%～10.5%,方法可满足定量分析的要求。     

液相色谱-串联质联法测定食品用塑料包装中邻苯二甲酸酯类增塑剂

采用液相色谱-串联质谱法(LC-MS/MS)测定了食品用塑料包装材料中的3种邻苯二甲酸酯(DBP、BBP、DEHP)的含量。样品经正己烷超声提取后,以Hypersil Gold色谱柱为固定相,以甲醇-水(95+5)溶液为流动相进行洗脱,采用电喷雾正离子源-多反应检测模式检测。3种邻苯二甲酸酯的质量浓度在5.00~250μg·L-1范围内与其峰面积呈线性关系,方法的检出限(3S/N)在0.1~0.2μg·L-1之间。对空白样品进行加标回收试验,回收率在92.5%~101%之间,测定值的相对标准偏差(n=6)在4.6%~6.9%之间。     

烤鳗中6种农药残留量的液相色谱-质谱/质谱法同时测定

建立了烤鳗中苯胺灵、嘧菌酯、氨苯乙酯、氟酮唑草、丙蝇驱、唑螨酯6种农药残留的同时检测方法.烤鳗样品采用乙腈、中性氧化铝超声基体分散吸附、涡旋混合提取,Florisil固相萃取小柱净化、浓缩,以乙腈-乙酸铵缓冲液为流动相进行色谱分离,串联质谱检测.结果表明,6种化合物在0.5 ～1 000 μg/L范围内线性关系良好,方法的检出限为0.03 ～2.3 μg/kg,定量下限为0.09 ～7.7 μg/kg,平均加标回收率为75% ～104%,相对标准偏差(RSD)为1.6% ～15%,满足当前进出口残留控制要求.     

液相色谱-串联质谱法测定牛奶中11种真菌毒素残留量

采用液相色谱-串联质谱法测定牛奶中11种真菌毒素的残留量。样品经乙腈沉淀蛋白和提取,正己烷脱脂,无水硫酸钠干燥,M160型多功能净化柱净化。以Agilent Eclipse XDB-C18色谱柱为分离柱,以不同体积比的水和甲醇混合液为流动相进行梯度洗脱,采用多反应监测模式检测。11种真菌毒素的质量分数均在4.0μg·kg-1以内与其峰面积呈线性关系,方法的检出限(3S/N)在0.001~0.006ng之间。加标回收率在60.1%~95.2%之间,测定值的相对标准偏差(n=6)在3.2%~9.6%之间。     

Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma

In the present study, a sensitive and fully validated bioanalytical high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) method has been developed for the quantitative determination of three newly synthesized carbonic anhydrases inhibitors (CAIs) with potential antitumor activity in human plasma. The analytes and the internal standard (IS) were extracted using 1.5 mL acetonitrile from only 450 µL aliquots of human plasma to achieve the desired protein precipitation. Chromatographic separations were achieved on Phenomenex Kinetex^® C₁₈ column (100 × 4.6 mm, 2.6 µm) using a binary gradient elution mode with a run time of less than 6 min. The mobile phase consisted of solvent (A): 0.1% formic acid in 50% methanol and solvent B: 0.1% formic acid in acetonitrile (30:70, v/v), pumped at a flow rate of 0.8 mL/min. Detection was employed using triple quadrupole tandem mass spectrometer (API 3500) equipped with an electrospray ionization (ESI) source in the positive ion mode. Multiple reaction monitoring (MRM) mode was selected for quantitation through monitoring the precursor-to-parent ion transition at m/z 291.9 → 173.0, m/z 396.9 → 225.1, m/z 388.9 → 217.0, and m/z 146.9 → 91.0 for AW-9a, WES-1, WES-2, and Coumarin (IS), respectively. Linearity was computed using the weighted least-squares linear regression method (1/x²) over a concentration range of 1–1000, 2.5–800, and 5–500 ng/mL for AW-9a, WES-1, and WES-2; respectively. The bioanalytical LC-MS/MS method was fully validated as per U.S. Food and Drug Administration (FDA) guidelines with all respect to linearity, accuracy, precision, carry-over, selectivity, dilution integrity, and stability. The proposed LC-MS/MS method was applied successfully for the determination of all investigated drugs in spiked human plasma with no significant matrix effect, which is a crucial cornerstone in further therapeutic drug monitoring of newly developed therapeutic agents.     

液相色谱-串联质谱法测定桃中31种农药残留

取均质后的桃皮或桃肉,在匀浆机上用乙腈提取;加入氯化钠及硫酸镁振荡盐析;取上清液与PSA混匀并离心进行净化。取经滤膜过滤的滤液与水混匀后供液相色谱-串联质谱分析。用Agilent Eclipse plus C18 RRHT色谱柱为分离柱,用含甲酸的5mmol·L-1甲酸铵溶液与乙腈以不同比例的混合液作流动相进行梯度淋洗。质谱测定中采用电喷雾正离子源动态多反应监测模式进行检测。所测31种农药在一定质量分数范围内保持线性关系,方法的检出限(3S/N)在0.04~20μg·kg-1之间,回收率在73.6%~119%之间,测定值的相对标准偏差(n=6)在0.70%~17%之间。     

液相色谱串联质谱法(LC-MS/MS)分析宠物食品中三聚氰胺

三聚氰胺(melamine)为白色或无色结晶,通常用于塑料制品中合成树脂的生产中,高温和酸性条件下能引起三聚氰胺转移到食品中.三嗪类农药环丙氨嗪(cyromazine)在极端的pH条件下或者光降解的条件下也能生成三聚氰胺.     

Development and Validation of a Sensitive LC-MS/MS Method for the Simultaneous Analysis of Three-Tropane Alkaloids in Blood and Urine

A simple and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed for the simultaneous analysis of three tropane alkaloids in blood and urine. After 1 mL of a blood or urine sample was extracted using a liquid–liquid extraction method with ethyl acetate at pH 8 and homatropine as the internal standard, the tropane alkaloids were separated. An Allure PFP propyl column (50 mm × 2.1 mm, 5 µm) separated the tropane alkaloids using an acetonitrile-buffer solution (20 mmol/L ammonium acetate and 0.1% formic acid, pH 4) (70:30) as the mobile phase at a flow-rate of 0.2 mL/min in isocratic mode, with the LC-MS/MS in the positive ionization mode. For each compound, detection was related to two daughter ions (scopolamine: m/z 304.4 → 138.1 and 155.9; atropine: m/z 290.3 → 124.0 and 93.1; anisodamine: m/z 306.3 → 140.1 and 91.1; and homatropine: m/z 276.3 → 124.3 and 142.1). The tropane alkaloids exhibited excellent linearity in the range of 0.05–100 ng/mL in blood and 0.2–100 ng/mL in urine, with a limit of detection range from 0.02 to 0.05 ng/mL for biological materials. The extraction recoveries of atropine, scopolamine, and anisodamine were more than 53% in the blood and urine; the interday and intraday RSDs were less than 10%; the within-day and between-day accuracy were between ?9.8% and +8.8%. The present method is simple and rapid, as shown by its application to a clinical case. This method is useful for routine analysis of tropane alkaloids in cases of suspected tropane alkaloid poisoning.     

液相色谱-串联质谱法测定蜂蜜中双甲脒及其代谢产物残留量

称取蜂蜜样品2.00g,加入同位素内标40ng,用pH7的磷酸二氢钾-磷酸氢二钠缓冲溶液溶解并稀释至10.0mL。充分混匀后,加入乙腈10.0mL和氯化钠2.0g,离心涡旋提取5min。取上层乙腈相保留待用,于下层水相中再加入乙腈10mL重复提取1次。合并两次提取液,加乙腈定容至20.0mL。分取此提取液1.0mL,加入于己预置N-丙基乙二胺(PSA)25mg、十八烷基硅烷(C18)10mg和MgSO430mg的离心管中,充分混匀后,高速离心,进行分散固相萃取(dSPE)净化。转移全部上清液,加水定容至2.0mL,此溶液供液相色谱-串联质谱法(LC-MS/MS)分析。色谱分离中采用XDB-C18色谱柱为固定相,用不同比例的φ0.15%甲酸溶液(A)和乙腈(B)的混合液作为流动相进行梯度淋洗。所得各洗脱液按工作条件进行MS/MS测定双甲脒及其代谢物单甲脒、2,4-二甲基苯基甲酰胺和2,4-二甲基苯胺的残留量。由于采用空白蜂蜜作基体加入混合标准溶液制作工作曲线,并加入同位素内标参与定量,有效地克服了基质效应。上述4种化合物工作曲线的线性范围为0~100μg·kg^-1,测定下限(10S/N)依次为0.10,0.20,5.0,2.0μg·kg^-1。在实际样品基体中加入3个浓度水平的标准溶液(5.0,10,20μg·kg^-1)进行回收试验,测得回收率均大于80%,测定值的相对标准偏差(n=6)均小于10%。所提出方法具有简便、快速的优点,其测定下限能满足目前国内外的规定要求。